Special Drug Use Surveillance of Irribow in Female Patients
Status:
Completed
Trial end date:
2018-03-31
Target enrollment:
Participant gender:
Summary
The purpose of the survey is to evaluate the safety and efficacy of Irribow and Irribow OD
Tablets in post-marketing medical practice and to examine the status of treatment compliance.